Prestige Biologics Co., Ltd. (KOSDAQ: 334970)
South Korea
· Delayed Price · Currency is KRW 4,810.00
+10.00 (0.21%)
Jan 22, 2025, 9:00 AM KST
Prestige Biologics Market Cap
Prestige Biologics has a market cap or net worth of 371.60 billion as of January 22, 2025. Its market cap has increased by 38.07% in one year.
Market Cap
371.60B
Enterprise Value
440.23B
Revenue
1.60B
Ranking
n/a
PE Ratio
n/a
Stock Price
4,810.00
Market Cap Chart
Since March 11, 2021, Prestige Biologics's market cap has decreased from 613.27B to 371.60B, a decrease of -39.41%. That is a compound annual growth rate of -12.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 22, 2025 | 372.38B | -5.50% |
| Dec 30, 2024 | 394.06B | 46.25% |
| Dec 28, 2023 | 269.45B | 46.01% |
| Dec 29, 2022 | 184.55B | -59.28% |
| Dec 30, 2021 | 453.18B | -26.10% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Electronics | 355.59T |
| SK hynix | 150.21T |
| LG Energy Solution | 82.95T |
| Samsung Biologics Co.,Ltd. | 71.25T |
| Hyundai Motor Company | 45.49T |
| Kia Corporation | 39.35T |
| Celltrion | 38.12T |
| KB Financial Group | 33.29T |